Business Description
Vanta Bioscience Ltd
ISIN : INE695X01011
Share Class Description:
BOM:540729: Ordinary SharesTotal Employee Number:
36Compare
Compare
Traded in other countries / regions
540729.India IPO Date
2017-10-06Description
Vanta Bioscience Ltd is a full-service preclinical contract research organization based in Chennai, India, providing preclinical safety assessment services for the pharmaceutical, medical devices, nutraceuticals, biotech, agrochemicals, cosmetics, chemical, and feed additive industries. Established as a center of excellence in GLP-compliant toxicology and safety assessment, the company supports clients through toxicology studies, batch release tests, biocompatibility evaluations, agro-chemical and chemical safety assessments, and diet formulation services. It also offers testing and contract research services in clinical and pre-clinical research, biopharma studies, analytical testing, and environmental assessments.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.8 | |||||
Debt-to-EBITDA | 30.55 | |||||
Interest Coverage | 0.81 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.32 | |||||
Beneish M-Score | -1.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -36.7 | |||||
3-Year FCF Growth Rate | 28.8 | |||||
3-Year Book Growth Rate | 2.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.3 | |||||
9-Day RSI | 4.75 | |||||
14-Day RSI | 16.57 | |||||
3-1 Month Momentum % | 36.7 | |||||
6-1 Month Momentum % | 29.69 | |||||
12-1 Month Momentum % | -1.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 0.56 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 460.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | 191.53 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 149.14 | |||||
Operating Margin % | 34.77 | |||||
Net Margin % | 5.96 | |||||
EBITDA Margin % | 68.62 | |||||
FCF Margin % | -287.35 | |||||
OCF Margin % | -287.35 | |||||
ROE % | 0.64 | |||||
ROA % | 0.16 | |||||
ROIC % | 0.91 | |||||
3-Year ROIIC % | -47.74 | |||||
ROC (Joel Greenblatt) % | 3.29 | |||||
ROCE % | 1.21 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 145 | |||||
PE Ratio without NRI | 145 | |||||
PS Ratio | 8.51 | |||||
PB Ratio | 0.73 | |||||
EV-to-EBIT | 84.58 | |||||
EV-to-EBITDA | 42.85 | |||||
EV-to-Revenue | 29.41 | |||||
EV-to-FCF | -10.23 | |||||
Price-to-GF-Value | 1.84 | |||||
Earnings Yield (Greenblatt) % | 1.18 | |||||
FCF Yield % | -33.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vanta Bioscience Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 18.164 | ||
| EPS (TTM) (₹) | 0.15 | ||
| Beta | 1.0291 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.25 | ||
| Volatility % | 66.44 | ||
| 14-Day RSI | 16.57 | ||
| 14-Day ATR (₹) | 0.303101 | ||
| 20-Day SMA (₹) | 24.678 | ||
| 12-1 Month Momentum % | -1.29 | ||
| 52-Week Range (₹) | 14.71 - 29 | ||
| Shares Outstanding (Mil) | 7.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vanta Bioscience Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vanta Bioscience Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vanta Bioscience Ltd Frequently Asked Questions
What is Vanta Bioscience Ltd(BOM:540729)'s stock price today?
The current price of BOM:540729 is ₹21.75. The 52 week high of BOM:540729 is ₹29.00 and 52 week low is ₹14.71.
When is next earnings date of Vanta Bioscience Ltd(BOM:540729)?
The next earnings date of Vanta Bioscience Ltd(BOM:540729) is .
Does Vanta Bioscience Ltd(BOM:540729) pay dividends? If so, how much?
Vanta Bioscience Ltd(BOM:540729) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vanta Bioscience Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers